top of page

BackTable / OBGYN / Contributor

Dr. Aditya Bagrodia on the BackTable OBGYN Podcast

Dr. Aditya Bagrodia

Genioturinary Oncologist

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Listen to Dr. Aditya Bagrodia on the BackTable OBGYN Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Aditya Bagrodia and get practical advice on how to build your practice by listening to the BackTable OBGYN Podcast.

Ep 57 AI Scribes: Enhancing Patient & Physician Interaction with Elie Toubiana
00:00 / 01:04
BackTable CMEfy button

Stay Up To Date

Follow:

Subscribe:

Sign Up:

About Dr. Aditya Bagrodia

Aditya Bagrodia, M.D., is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Dr. Bagrodia holds a bachelor of science degree from Rhodes College. While earning a medical degree with highest honors at the University of Tennessee Health Sciences Center, he was awarded a Doris Duke Clinical Research Fellowship at UT Southwestern Medical Center.

After completing his residency in urology at UT Southwestern, he received advanced training in urologic oncology through a fellowship at Memorial Sloan Kettering Cancer Center, where he was awarded a Urology Care Foundation Research Scholars Grant by the American Urological Association.

Dr. Bagrodia’s clinical practice focuses on treating all urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile, and testicular cancers. He has expertise in complex multidisciplinary management and minimally invasive approaches to urologic surgery.

Dr. Bagrodia has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He is funded through competitive grants from the Cancer Prevention and Research Institute of Texas (CPRIT), intramural research grants, and the National Institutes of Health.

Both his clinical practice and research centers on patients with germ cell tumors (most commonly testicular cancer). His laboratory focuses on sequencing efforts to understand tumor evolution and heterogeneity in germ cell tumors and identifying novel biomarkers to recognize occult metastatic disease. The Bagrodia lab also conducts experiments in cell lines, zebrafish germ cell tumor models, and mice to understand the biologic implications of genetic alterations that are seen exclusively among patients with cisplatin-resistance disease. He is actively working on molecular biomarkers to identify minimal residual disease burden. On the clinical side, Dr. Bagrodia is actively involved in understanding and overcoming unique socioepidemiologic considerations that adversely impact oncologic outcomes in patients with germ cell tumors. He is also the principal investigator for several germ cell tumor-directed clinical trials at UT Southwestern (including NCT03426865 and NCT02537548).

Dr. Bagrodia is the principal author or co-author of more than 100 articles in peer-reviewed publications such as Journal of Clinical Oncology, Nature Genetics, European Urology, Journal of Urology, Urologic Oncology, and Urology. He is also a reviewer for many of these publications, as well as for the British Journal of Urology, Journal of Clinical Pathology, and Annals of Surgical Oncology.

Learn more by visiting Dr. Aditya Bagrodia's practice:

Podcasts Featuring Dr. Aditya Bagrodia

Episode #57

OBGYN

Dr. Aditya Bagrodia sits down with Elie Toubiana, founder and CEO of ScribeMD.ai, to discuss the transformative potential of artificial intelligence (AI) in medical documentation.

Episode #27

OBGYN

In this episode of BackTable Urology, Dr. Aditya Bagrodia speaks with PGY4 urologist Dr. Chloe Peters (University of Washington) and OB/GYN Dr. Beverly Gray (Duke University) about their work in women's health and advocacy, and how the Dobbs ruling has impacted their respective medical fields.

Episode #19

OBGYN

In this episode of BackTable, Dr. Bagrodia interviews Dr. William Flanary, a physician-comedian popularly known as Dr. Glaucomflecken, about lessons he has learned as a two-time testicular cancer survivor and the importance of humor in medicine.

Episode #9

OBGYN

In this episode, Dr. Bagrodia discusses cultivating a healthy culture inside and outside of the operating room with Dr. Chris Kane, Dean of Clinical Affairs at UCSD and CEO of the UCSD Physician Group.

Get Connected

Thank you for listening! If you have a question for Dr. Aditya Bagrodia about a topic discussed on the BackTable OBGYN Podcast, you can get in touch with this form. Please note that our contributors are not able to respond to every inquiry.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-earn-free-cme.jpg
backtable-plus-vi-cta.jpg

Podcasts

AI Scribes: Enhancing Patient & Physician Interaction with Elie Toubiana on the BackTable OBGYN Podcast)
Dobbs vs Jackson: How Changing Abortion Laws are Impacting the Medical Workforce with Dr. Beverly Gray and Dr. Chloe Peters on the BackTable OBGYN Podcast)
When Providers Become Patients: Testicular Cancer and Beyond with Dr. William Flanary aka Dr. Glaucomflecken on the BackTable OBGYN Podcast)
Creating Culture Through Leadership and Mentoring with Dr. Christopher Kane on the BackTable OBGYN Podcast)
In-Depth: Endometrial Ablation with Dr. Barbara Levy on the BackTable OBGYN Podcast)

More Contributors

Dr. Christopher Kane on the BackTable OBGYN Podcast

Dr. Christopher Kane

bottom of page